Journal article

Treatment for hepatitis C virus infection among current injection drug users in Australia

G Matthews, IJ Kronborg, GJ Dore

CLINICAL INFECTIOUS DISEASES | OXFORD UNIV PRESS INC | Published : 2005

Abstract

An estimated 210,000 people were living with hepatitis C virus (HCV) infection in Australia at the end of 2001, and the number of people developing cirrhosis was projected to increase 4-fold by 2020. Eighty percent of prevalent and 90% of incident HCV infections are related to injection drug use. Current injection drug use was an exclusion criterion for access to government-funded treatment for HCV infection until May 2001. Despite the removal of this barrier to treatment access for current injection drug users (IDUs), the number of IDUs receiving treatment remains extremely low. Treatment outcomes among IDUs with chronic HCV infection treated at 2 public hospital-based hepatitis clinics are..

View full abstract

University of Melbourne Researchers